Overview

Oral Dydrogesterone as Luteal Phase Support in Natural Cycle FET

Status:
Recruiting
Trial end date:
2024-06-30
Target enrollment:
0
Participant gender:
Female
Summary
This randomised double-blinded controlled trial aims to compare the live birth rate in natural FET cycles with and without oral dydrogesterone as luteal phase support. The hypothesis is that the use of oral dydrogesterone will increase the live birth rate of natural cycle FET.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
The University of Hong Kong
Treatments:
Dydrogesterone
Criteria
Inclusion Criteria:

- Age of women <43 years at the time of stimulated IVF

- Replacing early cleavage embryos or blastocysts after thawing

Exclusion Criteria:

- Requiring hormonal replacement cycles

- Use of donor oocytes or embryos

- Undergoing preimplantation genetic testing

- Presence of hydrosalpinx not corrected surgically prior to FET

- Refusal to join the study